These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3902649)

  • 1. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
    Shepherd MG
    Infect Immun; 1985 Nov; 50(2):541-4. PubMed ID: 3902649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.
    Kirsch DR; Whitney RR
    Infect Immun; 1991 Sep; 59(9):3297-300. PubMed ID: 1879944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and morphological characterization of a mycelial mutant of Candida albicans.
    Hubbard MJ; Markie D; Poulter RT
    J Bacteriol; 1986 Jan; 165(1):61-5. PubMed ID: 3510192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
    Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models.
    Chamilos G; Nobile CJ; Bruno VM; Lewis RE; Mitchell AP; Kontoyiannis DP
    J Infect Dis; 2009 Jul; 200(1):152-7. PubMed ID: 19463063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low virulence of a morphological Candida albicans mutant.
    Diez-Orejas R; Molero G; Ríos-Serrano I; Vázquez A; Gil C; Nombela C; Sánchez-Pérez M
    FEMS Microbiol Lett; 1999 Jul; 176(2):311-9. PubMed ID: 10427713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal pathology and spleen cell chemiluminescence of mice infected with a wild-type and a low-virulence mutant of Candida albicans.
    Fromtling RA; Abruzzo GK; Edison A; Manning-Zweerink M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):405-15. PubMed ID: 3043983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae.
    Brennan M; Thomas DY; Whiteway M; Kavanagh K
    FEMS Immunol Med Microbiol; 2002 Oct; 34(2):153-7. PubMed ID: 12381467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological attributes of colony-type variants of Candida albicans.
    Dutton S; Penn CW
    J Gen Microbiol; 1989 Dec; 135(12):3363-72. PubMed ID: 2699892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice.
    Aoki S; Ito-Kuwa S; Nakamura Y; Masuhara T
    Zentralbl Bakteriol; 1990 Aug; 273(3):332-43. PubMed ID: 2206203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans.
    Vilela MM; Kamei K; Sano A; Tanaka R; Uno J; Takahashi I; Ito J; Yarita K; Miyaji M
    Med Mycol; 2002 Jun; 40(3):249-57. PubMed ID: 12146754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid destruction of skeletal muscle fibers by mycelial growth forms of Candida albicans.
    Ashman RB; Fulurija A; Robertson TA; Papadimitriou JM
    Exp Mol Pathol; 1995 Apr; 62(2):109-17. PubMed ID: 8549694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans--do mycelia matter?
    Ryley JF; Ryley NG
    J Med Vet Mycol; 1990; 28(3):225-39. PubMed ID: 2213438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis.
    Cole MF; Bowen WH; Zhao XJ; Cihlar RL
    FEMS Microbiol Lett; 1995 Feb; 126(2):177-80. PubMed ID: 7705609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients.
    Antony G; Saralaya V; Gopalkrishna Bhat K; Shalini Shenoy M; Shivananda PG
    Rev Iberoam Micol; 2009 Sep; 26(3):202-5. PubMed ID: 19635443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to yeast and mycelial forms of Candida albicans in intraperitoneally infected mice.
    Ponton J; Regulez P; Cisterna R
    Mycopathologia; 1986 Apr; 94(1):11-7. PubMed ID: 3523252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethality of Candida strains as influenced by the host.
    Saltarelli CG; Gentile KA; Mancuso SC
    Can J Microbiol; 1975 May; 21(5):648-54. PubMed ID: 1092440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.
    Wysong DR; Christin L; Sugar AM; Robbins PW; Diamond RD
    Infect Immun; 1998 May; 66(5):1953-61. PubMed ID: 9573075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.